Ozempic hype forces employer calls on obesity coverage
Spending on a new class of diabetes and weight loss medications hit nearly $7 billion in the first half of the year, as people are clamoring for these highly effective drugs. Employer health insurance plans are shouldering the bulk of that financial burden as half of Americans get their coverage through work. “The cost of…